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Abstract: Serum alkaline phosphatase (ALP), a well-known marker of hepatobiliary and bone
disorders, has recently been discovered to be a biochemical marker of cardiometabolic diseases
and chronic low-grade inflammation. We aimed to evaluate the association of serum ALP level
with knee osteoarthritis in the general population. The study included 3060 men and women aged
≥50 years who participated in the 2009–2011 Korea National Health and Nutrition Examination Survey.
The participants were categorized into three groups based on log-transformed serum ALP level as
follows: T1 (1.74–2.32), T2 (2.33–2.43), and T3 (2.44–3.01). Their radiographs were evaluated by two
well-trained radiologists using the Kellgren–Lawrence (KL) grading system. After excluding those
with KL Grade 0, we categorized the remaining participants into two groups, a severe osteoarthritis
group (KL Grade 4) and a non-severe osteoarthritis group (KL Grades 1 to 3). The odds ratios (ORs)
with 95% confidence intervals (CIs) of severe osteoarthritis according to the tertiles of log-transformed
serum ALP levels of patients with osteoarthritis were calculated using a weighted multivariate logistic
regression analysis. Compared with T1, the adjusted ORs (95% CIs) for severe osteoarthritis of the T3
serum ALP group was 1.613 (1.087–2.394; p = 0.018) after adjusting for the confounding variables.
Conclusively, serum ALP activity was independently and positively associated with severe knee
osteoarthritis in middle-aged and older adults.
Keywords: serum alkaline phosphatase; severe knee osteoarthritis; low-grade inflammation
1. Introduction
Osteoarthritis is the most common type of arthritis in old adults, with a substantial cost to the
individual and society [1,2]. The Centers for Disease Control and Prevention reported that 240 million
people worldwide have osteoarthritis, including >30 million people in the United States, an increase
from 21 million in 1990 to 27 million in 2005. In South Korea, the prevalence of knee osteoarthritis has
been estimated to be 4.5% among men and 19% among women according to the 2010–2012 Fifth Korean
National Health and Nutrition Examination Survey (KNHANES-V) [3]. While the development and
progression of osteoarthritis vary between individuals, most people have joint pain and functional
limitations [4].
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In the past, osteoarthritis was considered a result of aging and identified as a joint degenerative
disease [5]. However, the pathophysiological mechanisms of osteoarthritis are still under discussion.
More recently, the multifactorial risk factors of osteoarthritis, such as genetic factors, obesity,
and subclinical inflammation, have been associated with the progressive phases of cartilage
degeneration [6]. The severity of osteoarthritis commonly ranges from an asymptomatic, incidental
finding from a radiological examination to advanced incapacitating disorder [4]. The severe cartilage
loss in osteoarthritis leaves “joint failure” with disability and deteriorated quality of life, and contributes
to mortality [3]. Alkaline phosphatase (ALP) is primarily derived from the bones, liver, and placenta.
Abnormal ALP levels in blood have long been regarded to be associated with liver, gall bladder,
and bone disorders. However, emerging evidence suggests that serum ALP level is considered an
inflammatory mediator associated with cardiometabolic diseases, including metabolic syndrome, type 2
diabetes, hypertension, and dyslipidemia [7,8]. Moreover, other osteoarthritis-predictive inflammatory
markers such as C-reactive protein (CRP) level and leukocyte count increased with increasing serum
ALP levels [9–12]. In recent years, accumulated evidence shows that systemic low-grade inflammation,
which reflects metabolic overload, plays an important role in the pathogenesis and progression of
osteoarthritis [13,14].
In light of these novel findings, we aimed to investigate the relationship between serum ALP
levels and knee osteoarthritis in a Korean population aged ≥50 years, using data from the 2009 to
2011 KNHANES.
2. Materials and Methods
2.1. Study Population
All the data used in this study were obtained from the 2009 to 2011 Korean National Health
and Nutrition Examination Survey. The KNHANES, a nationwide representative survey conducted
by the Korea Centers for Disease Control and Prevention (KCDC), has a cross-sectional, multistage,
stratified, probability sampling design based on sex, age, and geographical area. To capture a sample
representing the general Korean population, participants are assigned sample weights. The detailed
methods associated with the KNHANES have been described previously [15].
Among the 7759 adults aged ≥50 years with knee radiographs who participated in the 2009–2011
KNHANES, we applied the following exclusion criteria: (1) no abnormal findings on knee radiographs
(n = 2792), (2) missing data on serum ALP level (n = 403), (3) positive for hepatitis B viral surface
antigen (n = 149), (4) heavy alcohol consumer (n = 211), (5) patients with rheumatoid arthritis
(n = 147), (6) patients with osteoporosis (n = 456), or (7) presence of osteoporosis on dual energy
X-ray absorptiometry (n = 541). Finally, 3060 participants were included in the study (Figure 1).
Written informed consent was provided to each participant by the KCDC during the survey. The use of
KNHANES data was approved by the Institutional Review Board of the Korea Centers for Disease
Control and Prevention (IRB No. 2009-01CON-03-2C, 2010-02CON-21-C, 2011-02CON-06-C). The data
used in this study are available for free on the KNHANES website (http://knhanes.cdc.go.kr) for
academic research purposes.
2.2. Biochemical Measurements
After at least 8 h of fasting, blood samples were collected from the antecubital vein from
each participant. Serum total cholesterol, vitamin D, aspartate aminotransferase (AST), alanine
aminotransferase (ALT), ALP, and plasma glucose concentrations were measured using a Hitachi 7600
Analyzer. We used log-transformed serum ALP level instead of serum ALP level in this study because
the serum ALP levels of the participants had a skewed distribution. The participants were divided into
three groups according to the tertile of log-transformed serum ALP levels as follows: T1 (1.74–2.32),
T2 (2.33–2.43), and T3 (2.44–3.01).
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Figure 1. Flowchart of study population selection.
2.3. Assessment of Knee Osteoarthritis
The participants underwent bilateral standing anteroposterior and lateral radiography of both
knees using a SD3000 Synchro Stand (Accele Ray Shinyoung Co., Seoul, Korea). The radiographs
were evaluated by two well-trained radiologists using the Kellgren–Lawrence (KL) grading system
as follows [16]: Grade 0 = normal, no radiological findings of osteoarthritis; Grade 1 = doubtful of
osteoarthritis, doubtful narrowing of the joint space and possible osteophytic lipping; Grade 2 = mild
osteoarthritis, definite osteophytes and possible narrowing of the joint space; Grade 3 = moderate
osteoarthritis, moderate multiple osteophytes, definite narrowing of the joint space, small pseudocystic
areas with sclerotic walls, and possible deformity of bone contour; Grade 4 = severe osteoarthritis,
large osteophytes, marked narrowing of the joint space, severe sclerosis, and definite deformity of
the bone contour. After excluding those with KL Grade 0, we categorized the participants into two
groups, a severe osteoarthritis group (KL Grade 4) and a n n-severe osteoarth itis group (KL Grades 1
to 3). Participants with at least KL Grade 1 on their knee radiographs were ask d whether they had
knee pain and assessed using a nume ical rating scale (NRS) ran ing from 0 (no pain to 10 (the worst
pain imaginable). We categorized the NRS sc res into four categories as follows: no pain, mild pain
(NRS scores of 1 to 3), moderate pain (NRS scores of 4 to 6), and severe pain (NRS scores of 7 to 10).
2.4. Covariates
F r the height and body weight measurements, the participants wore light indoor clothing without
shoes, and the values were rounded off to the nearest 0.1 cm and 0.1 kg, respectively. Body mass
index (BMI) was calculated as body weight divided by the square of height (kg/m2). Systolic and
diastolic blood pressures were defin d as the average of the last two of the three measured values.
Among participants who responded that they smoke currently, we defined those who had smoked at
least 100 cigarettes during their lifetime as current smokers [17]. Smoking status was divided into two
categories, current smoker and non-current smoker. The amount of alcohol intake was calculated as
the number of grams f alcohol consumed per day (g/day). After exclu ing heavy alcohol drinkers
who drank alcohol ≥30 g/day for men and ≥20 g/day for women, we divided alcohol drinking status
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as social drinker or non-drinker. The International Physical Activity Questionnaire-short form was
used to estimate the participants’ physical activity levels. Either vigorous activity for ≥20 min for
≥3 days/week or moderate-intensity activity for ≥30 min for ≥5 days/week were regarded as regular
exercise [18,19]. We divided the participants into two groups, those with and those without regular
exercise. Equivalized income was used to represent income considering household size. Monthly
household income was calculated by dividing the self-reported monthly household income by the
square root of the number of household members. Following this, monthly household income was
classified into quartiles (lowest, mid-lower, mid-higher, and highest) [20]. We classified employment
status as employed and unemployed.
For dietary surveillance, well-trained dietitians conducted in-person interviews with the
participants, using the 24-h recall method. The daily amounts of calcium (Ca; mg/day) and phosphorus
(P; mg/day) intakes were calculated using the data obtained through the 24-h recall method. The detailed
nutrition survey protocol is presented on the KNHANES website [21].
2.5. Statistical Analyses
The normal distribution of the serum ALP levels was evaluated along with a determination
of skewness using the Kolmogorov–Smirnov test. All data were presented as mean or percentage
(%) ± standard error (SE) values. The clinical characteristics of the study population according
to the tertiles of log-transformed serum ALP levels were compared using a weighted generalized
linear regression analysis for continuous variables and a weighted chi-square test for categorical
variables. The comparison of the mean values of the log-transformed serum ALP levels according
to osteoarthritis severity was analyzed using a weighted generalized linear regression analysis.
A weighted chi-square test was used to calculate the percentage of the participants with knee pain
according to osteoarthritis severity. The odds ratios (ORs) with 95% confidence intervals (CIs) for
severe osteoarthritis according to the tertiles of log-transformed serum ALP levels of the osteoarthritis
patients were calculated using weighted multivariate logistic regression analyses. The linear trends
across the tertiles of log-transformed serum ALP level were tested using the median value within
each tertile as a continuous variable. All statistical analyses were performed using SPSS version 25.0
statistical software (SPSS Inc., Chicago, IL, USA). The significance level was set at p < 0.05.
3. Results
3.1. Clinical Characteristics of the Study Population
Table 1 presents the clinical characteristics of 3060 subjects according to the tertiles of log-transformed
serum ALP levels. The mean age of the total population was 63.4 ± 0.2 years without statistical
significance. The proportion of male sex, social drinker, moderate osteoarthritis, and severe osteoarthritis
increased with increasing log-transformed serum ALP tertiles. The proportion of the lowest quartile
of monthly household income gradually increased as log-transformed serum ALP tertiles increased.
On the other hand, the proportion of the highest quartile of monthly household income gradually
decreased as log-transformed serum ALP tertiles increased. Similar trends but with no statistically
significant differences were observed in the proportion of current smokers, regular exercise, employed
status, and knee joint pain among the groups. The mean levels of plasma glucose, serum AST,
and ALT increased, and the mean vitamin D level decreased in accordance with the log-transformed
serum ALP tertiles. The mean values of BMI, dietary Ca intake, dietary P intake, and dietary Ca/P
intake ratio did not show statistical significance among the groups. Furthermore, as the severity
of osteoarthritis worsened, percentage of obese participants and the mean value of BMI increased
(Supplementary Material: Figures S1 and S2).
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T1 (1.74–2.32) T2 (2.33–2.43) T3 (2.44–3.01) Total p
Unweighted n 1017 1001 1042 3060
Male sex, % (SE) 52.8 (1.8) 50.9 (1.8) 44.0(1.9) 49.2(1.1) 0.003
Age, years 62.9 ± 0.4 63.2 ± 0.3 64.1± 0.4 63.4 ± 0.2 0.082
Body mass index, kg/m2 24.6 ± 0.1 24.6 ± 0.1 24.5± 0.1 24.6 ± 0.1 0.911
Dietary Ca intake, mg/day 504.4 ± 12.6 479.3 ± 12.9 485.8 ± 17.0 489.8 ± 9.2 0.289
Dietary P intake, mg/day 1131.0 ± 19.3 1122.8 ± 20.6 1076.7 ± 21.5 1110.2 ± 13.3 0.124
Dietary Ca/P ratio 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.375
Mean blood pressure, mmHg 92.8 ± 0.6 93.0 ± 0.5 94.2 ± 0.7 93.4 ± 0.3 0.218
Fasting plasma glucose, mg/dL 101.9 ± 0.7 102.6 ± 0.9 107.9 ± 1.2 104.1 ± 0.6 <0.001
Total cholesterol, mg/dL 191.7 ± 1.3 192.7 ± 1.4 194.7 ± 1.5 193.1 ± 0.8 0.293
Serum vitamin D, ng/mL 20.3 ± 0.3 19.6 ± 0.3 19.1 ± 0.3 19.7 ± 0.2 0.007
Serum AST, U/L 23.1 ± 0.3 23.4 ± 0.3 25.4 ± 0.5 24.0 ± 0.2 <0.001
Serum ALT, U/L 21.1 ± 0.5 21.7 ± 0.5 23.5 ± 0.6 22.1 ± 0.3 0.014
Current smoker, % (SE) 31.1 (2.4) 28.2 (2.0) 30.7 (2.1) 30.1 (1.2) 0.603
Current drinker, % (SE) 52.3 (2.0) 43.3 (1.9) 40.8 (1.7) 45.6 (1.1) <0.001
Regular exercise, % (SE) 22.9 (1.8) 19.5 (1.7) 19.9 (1.7) 20.8 (1.1) 0.256
Employed status, % (SE) 59.1 (2.0) 57.2 (1.9) 54.8 (2.0) 57.1 (1.3) 0.208
Monthly household income, % (SE) 0.001
Lowest 29.5 (1.9) 30.9 (1.8) 33.9 (1.8) 31.5 (1.2)
Medium-lowest 22.5 (1.8) 28.5 (1.6) 28.7 (1.9) 26.5 (1.1)
Medium-highest 22.7 (1.7) 21.8 (1.7) 21.8 (1.9) 22.1 (1.2)
Highest 25.2 (2.2) 18.8 (1.7) 15.6 (1.5) 19.9 (1.1)
Severity of OA, % (SE) 0.002
Probable OA 46.4 (1.9) 47.8 (2.0) 39.4 (2.1) 44.5 (1.2)
Mild OA 26.9 (1.8) 23.8 (1.7) 25.5 (1.7) 25.5 (1.1)
Moderate OA 19.2 (1.3) 20.8 (1.4) 23.0 (1.6) 21.0 (0.9)
Severe OA 7.5 (1.0) 7.6 (0.9) 12.0 (1.3) 9.1 (0.7)
Knee joint pain, % (SE) 0.544
No pain 76.5 (1.9) 76.9 (1.9) 73.1 (2.0) 75.4 (1.2)
Mild 3.7 (0.7) 3.6 (0.7) 4.0 (0.8) 3.8 (0.4)
Moderate 10.8 (1.4) 8.9 (1.3) 12.0 (1.4) 10.6 (0.7)
Severe 9.0 (1.1) 10.7 (1.4) 11.0 (1.3) 10.2 (0.8)
Abbreviations: KNHANES, Korea National Health and Nutrition Examination Survey; ALP, alkaline phosphatase;
Ca, calcium; P, phosphorus; AST, aspartate aminotransferase; ALT, alanine aminotransferase; OA, osteoarthritis; SE,
standard error.
3.2. Relationship between Serum ALP Level and Severe Osteoarthritis
Figure 2 shows the mean value of the log-transformed serum ALP levels according to knee
osteoarthritis severity. The mean log-transformed serum ALP levels were 2.38 and 2.41 in non-severe
and severe osteoarthritis, respectively (p < 0.001).
Figure 3 shows the percentages of the knee pain scale scores according to the log-transformed
ALP tertiles. Although the patients in the T3 groups complained of severe knee pain the most, the knee
pain severity was not significantly different among the groups (p = 0.544). Regardless of osteoarthritis
severity, the trends remained similar (p = 0.829 in the severe osteoarthritis subgroup and p = 0.551 in
the non-severe osteoarthritis subgroup, respectively).
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Table 2 shows the results of the weighted multivariate logistic regression model for the analysis of
the relationship between serum ALP level and severe osteoarthritis. The ORs (95% CIs) for severe
osteoarthritis of T3 compared with the referent T1 was 1.696 (1.182–2.433) (p = 0.004). Similar trends
were observed even after further adjustment for all potential confounding variables, including age, sex,
BMI, dietary Ca/P intake ratio, regular exercise, current smoking status, social drinking status, monthly
household income, employment status, and serum vitamin D level. The fully adjusted ORs (95% CIs) for
severe osteoarthritis of T3 compared with T1 was 1.613 (1.087–2.394) (p = 0.018). In addition, although
no significant difference was found in the odds of T2 and T1, the fully adjusted ORs with 95% CIs
increased according to the tertiles of log-transformed serum ALP level increments (p for trend = 0.017).
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Table 2. Odds ratios with 95% confidence intervals for severe osteoarthritis according to the tertiles of
log-transformed serum ALP level among osteoarthritis patients.
T1 T2 T3
ORs (95% CIs) p ORs (95% CIs) p Overall p p for Trend
Unadjusted 1 (ref) 1.025 (0.723–1.413) 0.889 1.696 (1.182–2.433) 0.004 0.004 0.004
Model 1 1 (ref) 1.036 (0.719–1.493) 0.848 1.528 (1.050–2.223) 0.027 0.045 0.025
Model 2 1 (ref) 1.077 (0.704–1.650) 0.731 1.620 (1.097–2.393) 0.016 0.035 0.015
Model 3 1 (ref) 1.079 (0.706–1.648) 0.726 1.613 (1.087–2.394) 0.018 0.039 0.017
Abbreviations: ORs, odds ratios; CIs, confidence intervals. Model 1: adjusted for age, sex, body mass index,
and dietary calcium/phosphate intake ratio. Model 2: adjusted for the variables used in Model 1 plus regular
exercise, current smoking status, social drinking status, monthly household income, and employed status. Model 3:
adjusted for the variables used in Model 2 plus serum vitamin D level.
4. Discussion
In this nationally representative cross-sectional study, we found that higher serum ALP levels were
positively associated with the presence of radiologically confirmed symptomatic knee osteoarthritis
in middle-aged and old adults. These positive associations were maintained after adjustment for
confounding variables, indicating that the elevated ALP levels are associated with a higher prevalence
of severe knee osteoarthritis. The participants with higher log-transformed serum ALP level (2.44–3.01)
had a 1.7-fold higher risk for the presence of severe knee osteoarthritis than the participants with
lower log-transformed serum ALP level (1.74–2.32). To our knowledge, only one previous animal
study has examined the relationship between synovial bone-specific ALP level and osteoarthritis in
22 horses. Fuller et al. reported a positive correlation between synovial bone-specific ALP level and
cartilage damage in equine osteoarthritis [22]. Although serum ALP level has been revealed as a major
biochemical marker for the evaluation of disease activity in ankylosing spondylitis and rheumatoid
arthritis, we believe that this study is the first to show a positive association between serum ALP level
and osteoarthritis in a nationwide general population [23,24].
The exact mechanism by which serum ALP level correlates with osteoarthritis is not fully
understood, but several possible reasons for this relationship warrant consideration. First, serum ALP
level could be linked to low-grade inflammation, which may cause an inflammatory response in
chondrocytes. Emerging studies have demonstrated that serum ALP level is positively and independently
associated with inflammatory markers such as CRP level and leukocyte counts [9,25]. In addition,
increased ALP expression can be a cellular reaction to inflammatory stimuli through purinergic signaling
which involves chronic inflammation. ALP plays a role in catalyzing pro-inflammatory adenosine
triphosphate to anti-inflammatory adenosine. In this context, it is more likely that serum ALP is an
epiphenomenon of inflammation rather than the cause of osteoarthritis [26]. Traditionally, osteoarthritis
has been considered a consequence of aging and mechanical burden. However, osteoarthritis is now
regarded as a complex interplay of biomechanical and cellular factors that contribute to the end-stage
pathology of the joints [27]. Accumulated evidence suggests that an imbalance in metabolic conditions
is a significant risk factor for the progression of osteoarthritis. The coexistence of metabolic syndrome
components such as overweight, hypertension, and diabetes showed an even higher prevalence
of hand osteoarthritis, which is a non-weight-bearing joint lesion [28]. Another study also found
that type 2 diabetes could be an independent risk factor of osteoarthritis, showing the concept of a
diabetes-induced osteoarthritis through a subclinical inflammation that has a potential impact on the
progression of osteoarthritis [29]. Moreover, Hiraiwa et al. reported that hyperglycemia has harmful
effects on human meniscal cells through advanced glycation end-products and reactive oxidative stress,
which cause subchondral bone destruction and chondrocyte dysfunction [30]. In this study, fasting
plasma glucose levels gradually increase in accordance with serum ALP quartiles. In this regard,
chronic low-grade systemic inflammation may describe positive associations between them.
Second, elevated serum ALP could be associated with chronic pain. Kamimura el al. found that
serum bone specific ALP were remarkably increased in elderly women with lower back pain [31].
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This study showed that the participants with severe knee osteoarthritis were more likely to experience
pain. Pain induced chronodisruption could be at least partly associated with severity of osteoarthritis.
It is well established that persistent pain can provoke sleep disturbance, which is directly connected
to alteration of the circadian rhythm. Inversely, sleep disruption can also alter pain processing and
lead to a higher prevalence of pain through sensitization and habituation [32]. Chronodisruption
could be linked to a substantial increase in inflammatory mediators such as CRP and tumor necrosis
factor-α levels, which were increased in osteoarthritic tissue [33–35]. As mentioned earlier, elevated
serum ALP levels were definitely associated with increased inflammatory mediators such as CRP level
and leukocyte counts [9,25]. In addition, Berenbaum et al. reported that metabolic dysregulation,
inflammatory pathways, and the daily rhythmic environment have all been connected to osteoarthritis
susceptibility through neuroendocrine systems such as cortisol and parathyroid hormone [36].
This study has some limitations that require explanation. We could not assess degenerative disc
disease, fat mass, skeletal muscle mass, synovial bone-specific ALP level, and other inflammatory
biomarkers, including adipokines and chemokines due to lack of data. In addition, there was no
information about patellar OA in the KNHANES. In addition, because participants only checked X-ray
on knees and hips in the KNHANES, presence of osteoarthritis in other joints could affect ALP levels
although there were no significant differences in serum ALP level according to the presence or severity
of hip osteoarthritis (data not shown). Finally, we could not evaluate knee osteoarthritis using the
Ahlbäck classification. Despite these potential limitations, our findings, using a complex sampling
analysis, could be representative of the actual condition of older Korean adults with osteoarthritis.
5. Conclusions
Serum ALP activity was independently and positively associated with severe knee osteoarthritis,
implying that serum ALP level might be a valuable additional surrogate biomarker in the evaluation
of severe knee osteoarthritis.
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